From the Service de Médecine Physique et de Réadaptation, CHU Clermont-Ferrand, INRA, Université Clermont Auvergne, Clermont-Ferrand, France (VR, CM, PG, EC); Service de neurologie, CHU Clermont-Ferrand, INSERM Clermont Auvergne Université, Clermont-Ferrand, France (PC, FT); Clinique Charcot, Sainte-Foy-lès-Lyon, France (CC-C); and Direction recherche clinique et Innovation, CHU Clermont-Ferrand, France (BP).
All correspondence should be addressed to: Emmanuel Coudeyre, MD, PhD, Service de Médecine Physique et de Réadaptation, CHU Clermont-Ferrand, Hôpital Nord, 61 Rue de Chateaugay, BP 30056, 63118 Cébazat, France.
Supported by Clermont-Ferrand University Hospital for funding (2012).
Each individual named as an author meets the uniform requirements for manuscripts submitted to biomedical journals criteria for authorship.
Vivien Reynaud is in training.
Financial disclosure statements have been obtained, and no conflicts of interest have been reported by the authors or by any individuals in control of the content of this article.
Supplemental digital content is available for this article. Direct URL citations appear in the printed text and are provided in the HTML and PDF versions of this article on the journal’s Web site (www.ajpmr.com).